BrightSpring Health Services (NASDAQ:BTSG) Shares Down 4.7% - Should You Sell?

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report)'s share price traded down 4.7% during trading on Tuesday . The stock traded as low as $23.03 and last traded at $22.61. 243,739 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 1,601,323 shares. The stock had previously closed at $23.72.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on BTSG shares. KeyCorp initiated coverage on BrightSpring Health Services in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. BTIG Research boosted their target price on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the company a "buy" rating in a research note on Thursday, October 3rd. UBS Group boosted their target price on BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday. Wells Fargo & Company upped their price objective on shares of BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, November 27th. Finally, Bank of America increased their target price on BrightSpring Health Services from $19.00 to $21.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.42.

BrightSpring Health Services Trading Down 1.9 %

The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The stock has a 50 day moving average of $18.72 and a 200 day moving average of $15.87. The firm has a market cap of $4.14 billion and a P/E ratio of -91.42.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). BrightSpring Health Services had a positive return on equity of 4.16% and a negative net margin of 0.38%. The business had revenue of $2.91 billion for the quarter, compared to analysts' expectations of $2.72 billion. BrightSpring Health Services's revenue was up 28.8% compared to the same quarter last year. As a group, equities research analysts predict that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Institutional Investors Weigh In On BrightSpring Health Services

Institutional investors have recently bought and sold shares of the stock. American Century Companies Inc. purchased a new position in BrightSpring Health Services during the 2nd quarter valued at about $216,000. Renaissance Technologies LLC grew its stake in BrightSpring Health Services by 12.3% in the second quarter. Renaissance Technologies LLC now owns 175,500 shares of the company's stock worth $1,994,000 after purchasing an additional 19,200 shares during the period. The Manufacturers Life Insurance Company raised its holdings in BrightSpring Health Services by 10.2% in the second quarter. The Manufacturers Life Insurance Company now owns 117,026 shares of the company's stock worth $1,329,000 after purchasing an additional 10,854 shares in the last quarter. SG Americas Securities LLC purchased a new position in BrightSpring Health Services during the third quarter valued at $360,000. Finally, nVerses Capital LLC boosted its holdings in shares of BrightSpring Health Services by 195.8% during the 3rd quarter. nVerses Capital LLC now owns 14,200 shares of the company's stock valued at $208,000 after buying an additional 9,400 shares in the last quarter.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.